Dow and broader stock-market futures turn positive amid upbeat report on Gilead's experimental coronavirus treatment

U.S. stock-index futures turned positive on Friday after a report from Gilead Sciences indicated that its experimental treatment for coronavirus was seeing positive results in reducing deaths. Futures for the Dow Jones Industrial Average YM00, +0.06% YMU20, +0.06% were up 0.1% at 25,600, those for the S&P 500 index ES00, +0.05% ESU20, +0.05% were trading up 0.

1% at 3,144, while Nasdaq-100 futures NQ00, +0.11% NQU20, +0.11% advanced 0.1% at 10,740. Gilead published a report on Friday saying that its antiviral drug remdesivir showed that it reduced the risk of death for coronavirus patients by 62% compared with standard care alone. The findings are being presented at the Virtual Covid-19 Conference as part of the 23rd International AIDS Conference, the company said.

😂😂

Dejavú

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Dow futures point to lackluster stock-market open as investors await weekly jobs dataU.S. stock-index futures Thursday morning see muted action as investors await a report on weekly jobless claims that is likely to show that more than one million Americans submitted claims for unemployment benefits amid the COVID-19 pandemic. Are they worried jobs will be added? Or excited that there will be jobs gone? I can’t tell anymore, the market is all coocoobananas. nobody gives a rat's ass they just buy it because Trump and the Fed tell them to
Source: MarketWatch - 🏆 3. / 97 Read more »